Rivaroxaban Tablets 10 mg, 15 mg, 20 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 15 mg, 20 mg
Reference Brands: Xarelto(US & EU), Rivabloc (India), Rivax (LATAM)
Category: Blood Disorder
Rivaroxaban inhibits factor Xa, reducing thrombin generation and clot formation. It effectively prevents strokes, deep vein thrombosis, and pulmonary embolism. Benefits include oral administration, predictable effects, no routine blood monitoring needed, and rapid onset, making it a convenient and effective anticoagulant for both prophylaxis and treatment of thromboembolic disorders.
Product Description:
Rivaroxaban is a widely used oral anticoagulant regulated by the FDA in the US and the EMA in the EU. It requires a robust dossier demonstrating safety, efficacy, and manufacturing quality for approval. In the US, it is approved as Xarelto, with a focus on stroke prevention, DVT, and PE treatment. In the EU, similar approvals are granted through centralized procedures, ensuring compliance with regional standards. For expert guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Ensuring regulatory compliance is critical for successful registration and commercialization of rivaroxaban products globally.
Rivaroxaban Tablets — third party manufacturing & bulk supply
Rivaroxaban Tablets 10 mg, 15 mg, 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Rivaroxaban Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Rivaroxaban Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Rivaroxaban is used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used for the prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery.
Rivaroxaban is a direct factor Xa inhibitor that selectively blocks factor Xa in the coagulation cascade, reducing thrombin generation and preventing clot formation.
The primary trade name is Xarelto, along with various generic brands available worldwide.
Rivaroxaban is manufactured by Bayer and is also produced by multiple pharmaceutical companies globally as a generic medicine.
The generic name is Rivaroxaban.
Brand names include Xarelto and other regional generics.
Rivaroxaban is manufactured in the USA, Europe, India, and other regions by multiple pharmaceutical companies under approved regulatory standards.
Related Products
Anagrelide Hydrochloride
Strength:
0.5 mg
Form: Capsules
Reference Brands: Agrylin (USA)
View Details
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View Details
Lusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
